Diskussionsleiter: M. Aslam (Gießen)
| (P1810) | Platelet-specific deficiency of soluble guanylyl cyclase expression promotes atherosclerosis | |
| M. Stroth, N. Bettaga, J. Wobst, J. Werner, A.-S. Zimmermann, A. Friebe, H. Sager, H. Schunkert, T. Keßler (München, Würzburg) | ||
| (P1811) | Effect of trimethylamine N-oxide (TMAO) on ADP-induced platelet reactivity following a loading dose of clopidogrel 600 mg | |
| C. Stratz, A. Gessner, M.-F. Fromm, J. Hromek, T. Nührenberg, L. Hille, W. Hochholzer, D. Trenk (Bad Krozingen, Erlangen) | ||
| (P1812) | Improving prolonged clot lysis in diabetes by affirmer A6 – a novel methodology | |
| K. Schütt, R. King, C. Tiede, V. Jankowski, V. John, A. Trehan, K. Simmons, S. Ponnambalam, C. W. Fishwick, M. J. McPherson, D. C. Tomlinson, R. A. Ajjan (Aachen; Leeds, UK) | ||
| (P1813) | Evaluation of benefits and risks of dual antiplatelet therapy after peripheral arterial interventions | |
| H. L. Busch, M. Stern, A. Karathanos, J. Eisenhuth, D. Schuler, A. Polzin, M. Kelm, C. Heiss, R. Sansone (Düsseldorf) |